TransMedics Group, Inc. (TMDX)
91.37
-0.63
(-0.68%)
USD |
NASDAQ |
Nov 13, 16:00
90.10
-1.27
(-1.39%)
After-Hours: 19:59
TransMedics Group Total Assets (Quarterly) : 1.518B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.518B |
| June 30, 2026 | 1.464B |
| March 31, 2026 | 1.435B |
| December 31, 2025 | 1.119B |
| September 30, 2025 | 946.03M |
| June 30, 2025 | 890.52M |
| March 31, 2025 | 837.53M |
| December 31, 2024 | 828.43M |
| September 30, 2024 | 785.57M |
| June 30, 2024 | 758.58M |
| March 31, 2024 | 723.83M |
| December 31, 2023 | 706.05M |
| September 30, 2023 | 689.23M |
| June 30, 2023 | 690.36M |
| March 31, 2023 | 287.09M |
| December 31, 2022 | 277.15M |
| September 30, 2022 | 274.87M |
| June 30, 2022 | 117.28M |
| Date | Value |
|---|---|
| March 31, 2022 | 124.01M |
| December 31, 2021 | 134.89M |
| September 30, 2021 | 131.15M |
| June 30, 2021 | 140.51M |
| March 31, 2021 | 145.78M |
| December 31, 2020 | 152.03M |
| September 30, 2020 | 159.32M |
| June 30, 2020 | 163.14M |
| March 31, 2020 | 96.92M |
| December 31, 2019 | 105.30M |
| September 30, 2019 | 112.62M |
| June 30, 2019 | 121.01M |
| March 31, 2019 | 38.76M |
| December 31, 2018 | 42.16M |
| September 30, 2018 | 48.40M |
| June 30, 2018 | 51.13M |
| March 31, 2018 | |
| December 31, 2017 | 37.00M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Boston Scientific Corp. | 45.46B |
| Insulet Corp. | 3.415B |
| Abbott Laboratories | 108.25B |
| Baxter International, Inc. | 19.41B |
| Becton, Dickinson & Co. | 50.79B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 967.22M |
| Shareholders Equity (Quarterly) | 550.71M |
| Debt to Equity Ratio | 1.574 |
| Current Ratio | 4.530 |
| Net Debt Paydown Yield | -2.40% |